-
E-mail
tailinmarketing@tailingood.com
- Phone
-
Address
Tailin Technology Park, No. 2930 Nanhuan Road, Binjiang District, Hangzhou City
Zhejiang Tailin Biotechnology Co., Ltd
Tailin Biotech @ CPHI SEA 2025 unlocks new potential in Southeast Asian pharmaceuticals
Date: 2025-07-21Read: 0
In the era of accelerated transformation in the global biopharmaceutical industry, Southeast Asia has become a new hotspot for competition and cooperation in the international pharmaceutical field with its booming market potential and industrial upgrading needs.
As an important annual pharmaceutical industry event in Southeast Asia, CPHI South East Asia 2025 is not only a stage for showcasing technological achievements, but also a bridge for deep integration of pharmaceutical resources. As a Chinese pharmaceutical equipment company, Tailin Biotech showcases cutting-edge solutions and knocks on the door to deep collaborative development with the Southeast Asian pharmaceutical industry.
At this exhibition, Tailin Biotech showcased key solutions covering the entire biopharmaceutical process, forming a multidimensional and systematic product matrix. From microbial detection, such as intelligent sterile detection systems and microbial limit detection systems, to microbial control, such as sterile isolators, glove integrity testers, vaporized hydrogen peroxide disinfectors, and to microbial validation, such as biological and chemical indicators, a complete set of efficient and closed-loop microbial detection and control systems has been constructed. TOC analyzer and fully automatic filter integrity tester have become important tools to ensure the compliant operation of critical water systems and filtration processes. Products such as online microbial rapid detection analyzer and packaging sealing integrity tester further enhance microbial monitoring and product safety assurance capabilities.
The exhibits showcased this time cover core areas such as aseptic production, leak testing, microbiological testing, and water quality safety testing, accurately responding to the actual needs of the Southeast Asian market in terms of GMP compliance upgrades and capacity optimization. They demonstrate Tailin Biotech's professional strength and comprehensive service capabilities in helping customers improve production efficiency and quality control. At the exhibition site, the Tailin Biotech booth attracted pharmaceutical executives, research experts, and industry decision-makers from multiple Southeast Asian countries such as Malaysia, Thailand, Singapore, and Indonesia to stop and exchange ideas. Through intensive technical communication and demand matching, Tailin Biotech not only further clarified the urgent needs of Southeast Asia's pharmaceutical industry in key areas such as compliance system construction and sterile process upgrading, but also provided strong support for subsequent customized solutions and project implementation, and laid a solid foundation for win-win cooperation between both parties. The debut of CPHI SEA 2025 is a key milestone in the promotion of Tailin Biotech's globalization strategy. As a pioneer enterprise in China's pharmaceutical equipment industry stepping onto the international stage, Tailin Biotech is building a three-dimensional cooperation network in the Southeast Asian market through technology output and value co creation, which includes "technology cooperation, production capacity coordination, and ecological co construction". In the future, enterprises will continue to be driven by technological innovation, guided by customer value, deepen cooperation with global partners, and contribute Chinese strength to promoting the compliance, intelligence, and sustainable development of the international biopharmaceutical industry, writing a new chapter in the process of global pharmaceutical industry chain reconstruction.
